title: Ménétrier's disease of the stomach: a clinical challenge.
abstract: Ménétrier's disease is a rare hyperproliferative protein-losing gastropathy of the gastric foveolar epithelium. Most common symptoms include epigastric pain with fullness and vomiting, and generalized peripheral edema with hypoalbuminemia. Radiologically, the wall of the gastric body and fundus is diffusely thickened, often with antral sparing. Giant rugal edematous folds are seen on gastroscopy, and histology of biopsy material shows diffuse foveolar hyperplasia with cystic dilatation of the glandular portion of the gastric mucosa in the absence of significant inflammatory infiltrate. The recent discovery of transforming growth factor α overexpression opens the way of epidermal growth factor receptor blockade with cetuximab as first-line treatment modality in severe cases of Ménétrier's disease.
authors.affiliation: Gastrointestinal Endocrinology, Long Beach VA Medical Center, 5901 East 7th Street, Building 1, Room 200M, Long Beach, CA 90822-5201, USA. nils.lambrecht2@va.gov
authors.forename: Nils W G
authors.initials: NW
authors.lastname: Lambrecht
mesh_terms: D005758:Gastritis, Hypertrophic / Q000175:diagnosis* / Q000209:etiology* / Q000378:metabolism / Q000628:therapy; D006801:Humans; D016211:Transforming Growth Factor alpha / Q000378:metabolism
chemical_list: D016211:Transforming Growth Factor alpha